CAMBRIDGE, Mass.


,


June 3, 2022


/PRNewswire/ —

Akebia Therapeutics, Inc.

(Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that

John Butler

, Chief Executive Officer, will present at the Jefferies Healthcare Conference on

Thursday, June 9, 2022

at

10:30 a.m. ET

. The Jefferies Healthcare Conference will take place

June 8-10, 2022

, in

New York

.

A live webcast of the presentation can be accessed through the Investors section of Akebia’s website at

https://ir.akebia.com

. A replay of the webcast will also be available for approximately 90 days following the conference through the Investors section of Akebia’s website at

https://ir.akebia.com

.

About Akebia Therapeutics

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in

Cambridge, Massachusetts

. For more information, please visit our website at

www.akebia.com

, which does not form a part of this release.

Akebia Therapeutics Contact


Mercedes Carrasco


[email protected]

View original content to download multimedia:

https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-jefferies-healthcare-conference-301560862.html

SOURCE Akebia Therapeutics